Nicole L Inniss, Ján Kozic, Fengling Li, Monica Rosas-Lemus, George Minasov, Jiří Rybáček, Yingjie Zhu, Radek Pohl, Ludmilla Shuvalova, Lubomír Rulíšek, Joseph S Brunzelle, Lucie Bednárová, Milan Štefek, Ján Michael Kormaník, Erik Andris, Jaroslav Šebestík, Alice Shi Ming Li, Peter J Brown, Uli Schmitz, Kumar Saikatendu, Edcon Chang, Radim Nencka, Masoud Vedadi, Karla J F Satchell
A collaborative, open-science team undertook discovery of novel small molecule inhibitors of the SARS-CoV-2 nsp16-nsp10 2'- O -methyltransferase using a high throughput screening approach with the potential to reveal new inhibition strategies. This screen yielded compound 5a , a ligand possessing an electron-deficient double bond, as an inhibitor of SARS-CoV-2 nsp16 activity. Surprisingly, X-ray crystal structures revealed that 5a covalently binds within a previously unrecognized cryptic pocket near the S -adenosylmethionine binding cleft in a manner that prevents occupation by S -adenosylmethionine...
September 20, 2023: ACS Infectious Diseases